Home > Our Members > Adjunct Members

Adjunct Members

Adjunct membership is for researchers employed by other institutions who collaborate with IDM Members to the extent that some of their own staff and/or postgraduate students may work within the IDM; for 3-year terms, which are renewable.


BARRY III, Dr Clifton
PhD, Section Chief and Senior Investigator, Tuberculosis Research Section (TRS), National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health (NIH).

Areas of interest span the basic sciences of chemistry, biochemistry and microbiology, through to pharmacology and clinical medicine, in the areas of mycobacterial pathogenesis and TB drug discovery research.

email


BROWN, Prof Gordon
PhD, FRS, FMedSci, FRSB, FAAM, FRSE, RSSAf, Director MRC Centre for Medical Mycology at the University of Exeter and Director of the AFGrica Unit at The University of Cape Town (UCT). Honorary Professor at UCT.

His primary research interests are C-type lectin receptors and their role in homeostasis and immunity, with a particular focus on antifungal immunity.

email


GRAY, Prof Clive
Professor Emeritus of Immunology, Division of Immunology, Department of Pathology, University of Cape Town; Professor of Immunology in Molecular Biology and Human Genetics, Stellenbosch University, Cape Town; Adjunct Professor, Department of Immunology, Duke University, North Carolina, USA; Secretary-General, Federation of African Immunology Societies; Vice-Chair, Education Committee of the IUIS; Director of the Immunopaedia Foundation.

His research interests revolve around investigating immune regulation and dysregulation in the context of HIV infection or exposure. He focuses on Immune ontogeny in HIV exposed infants, placental investigations and pre-term birth, and epithelial immunity in the foreskin. He has an active group within the IDM and is based at Stellenbosch University where he directs the Reproductive Immunology Research Consortium in Africa (RIRCA). He is the past Chair of Immunology at UCT and holder of several NIH and European-based grants.

email


GRAY, Prof Glenda
MBBCH, FCP (Paeds) SA. Executive Director Perinatal HIV Research Unit, Wits Health Consortium, University of Witwatersrand; Associate Professor, Department of Paediatrics, University of Witwatersrand, South Africa; HVTN Director of International Programmes; HVTN Co-Principal Investigator; Chair of the standing committee on Health, ASSAF.

Her Research Unit is involved with clinical research, epidemiology and operational research, and is a treatment site for HIV infected adults and children. Her research interests include HIV vaccine research, microbicide research and other biomedical and behavioural interventions, and she is an investigator in testing two HIV vaccine regimens in late stage clinical development. Her TB research includes examining new agents to prevent TB, TB prophylaxis and TB vaccine evaluation.

email


GROBUSCH, Prof Martin
Professor, Dr. Med. (M.D.), PhD, M.Sc. (Lond), DTM&H (Lond), FRCP (Lond). Specialist in Internal Medicine, Infectious Diseases, Tropical Medicine. Full Professor and Chair of Tropical Medicine and Travel Medicine and Head, Center of Tropical Medicine and Travel Medicine, Amsterdam Medical Centre, University of Amsterdam in the Netherlands.

He has been an author on over 150 manuscripts in the field of infectious diseases and has an extensive track record in infectious diseases research and practice covering clinical, laboratory and epidemiological aspects.

email


LESLIE, Dr Al
Principal investigator Africa Health Research Institute (AHRI), Durban, South Africa; Associate Professor, University of KwaZulu Natal, Durban, South Africa; Wellcome Trust senior Fellow, department of infection and immunity, University College London, UK.

He is an HIV and TB immunologist focused on studying the immune response to these pathogens in affected tissues, and how this relates to what can be observed from the blood. The research goal is to improve understanding of the immunopathology of TB and HIV, using this information to aid in developing novel therapeutic approaches and diagnostic biomarkers.

email


MOORE, A/Prof Penny
South African Research Chair in Viral Host Dynamics, Faculty of Health Sciences, University of Witwatersrand and National Institute for Communicable Diseases.

Her current research focuses on HIV broadly neutralising antibodies and their interplay with the evolving virus. Recent studies published in PloS Pathogens, Nature and Nature Medicine have highlighted the role of viral escape in creating new epitopes and immunotypes, thereby driving the development of neutralisation breadth, with implications for HIV vaccine design.

email


NICOL, Prof Mark
School of Biomedical Sciences, Division of Infection and Immunity, University of Western Australia; Professor in Microbiology.

Research interest in tuberculosis and in developing and testing point of care diagnostics suitable for the developing world.

email


REDD, Dr Andrew
PhD, Staff Scientist in International HIV and STD Section, National Institute of Allergy and Infectious Diseases at the US National Institutes of Health; Assistant Professor of Medicine at Johns Hopkins University.

His research is focused on better understanding HIV transmission and disease dynamics with a special concentration on HIV superinfection, latent HIV infection, and the role of the virus in HIV+ organ transplantation. 

email


WILKINSON, A/Prof Katalin
Principal Research Scientist at The Francis Crick Institute London; Honorary Associate Professor, Division of Infection and Immunity, University College London; Honorary Associate Professor, Department of Medicine, University of Cape Town.

Her research focuses on the immunology of HIV-associated tuberculosis (TB). More specifically, the reconstitution of the immune response during antiretroviral treatment, in order to identify correlates of protection (including immune mechanisms that lead to reduced susceptibility to TB), and pathogenesis (such as the Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, TB-IRIS); the biosignature of the TB infection spectrum, from latent infection to active disease; preventing TB infection in HIV infected people more effectively; and the pathogenesis of tuberculous meningitis and pericarditis.

email

TOP